In light of the pandemic situation events until September 2021 are cancelled. We will inform customers directly when the events are rescheduled.    
COVID CANCELLED: Project Management in Human Resources,   Boston MA, Jan 6-8, 2021
COVID CANCELLED: InterDrone, The International Drone Conference,   Cambridge MA, Jan 11-13, 2021
COVID CANCELLED: Supplier Management for Medical Device Manufacturers,   Cambridge MA, Feb 2-4, 2021
COVID CANCELLED: US Immigration Compliance Strategies,   Boston MA, Feb 15-18, 2021
COVID CANCELLED: Project Management Training,   Boston MA, Mar 3-5, 2021
COVID CANCELLED: Internal Audit, Fraud Risk Assessment Workshop,   Boston MA, Mar 22-25, 2021
COVID CANCELLED: Agile / Scrum Training,   Boston MA, Apr 12-14, 2021
COVID CANCELLED: Validation, Verification and Transfer of Analytical Methods,   Boston MA, Apr 19-21, 2021
COVID CANCELLED: Computer System Validation - Reduce Costs and Avoid 483s,   Boston MA, May 10-12, 2021
COVID CANCELLED: SharePoint Technology Conference,   Boston MA, May 26-28, 2021
COVID CANCELLED: Employment Laws Certificate Program,   Boston MA, Jun 7-9, 2021
Following events are tentatively planned but may be rescheduled, based on CDC guidelines or attendee registration interest .    
TENTATIVE: 21 CFR Part 11 Compliance,   Boston MA, Sep 22-24, 2021
TENTATIVE: Quality Control Laboratory Compliance,   Boston MA, Oct 6-8, 2021
TENTATIVE: Analytical Instrument Qualification and System Validation,   Boston MA, Nov 15-17, 2021
TENTATIVE: FDA's New Import Program for 2021,   Boston MA, Dec 7-9, 2021

Boston Professional Events List

3rd Annual Preclinical Development Operations Summit 2020

Nov 16, 2021 - 08:00 AM
BOSTON MA 10001,

ZIP: 10001

3rd Annual Preclinical Development Operations Summit 2020

14th - 15th November, Boston

The second edition of the Preclinical Development Operations Summit was a thought-provoking two days of engaging presentations, discussion and networking.

Chaired by Mr Barnett, Executive Chairman at Lubris Bio, the event focused on how to maximize your business relations with your internal and external collaborators. It included insightful presentations from Olivier Negre, Director of Translational Research, Bluebird Bio and Ajai Chaudhary, Director External Research and External Capabilities, Lead PPDM, Merck.

New FDA regulations in the preclinical space were pinpointed by Karin Zeh, Head of Program Management and Regulatory Operations, Zafgen. Dr Rakesh Dixit, Vice President, Research & Development, MedImmune AstraZeneca, our keynote speaker, addressed challenges to preclinical development of immune-oncology biologics. The event closed on a high note with a panel (including Sean Muthian, Executive Director, External Sciences Innovations, Allergan - Pamela Hill, Open Innovation Program Director, AstraZeneca - Ben Askew, Vice President of Research, SciFluor Life Sciences) discussing site monitoring.

Following on from this success, Arena International is pleased to announce that this unique event will be returning once again in November 2020.

The 2020 program aims to stay abreast of the latest industry trends and operational challenges in preclinical development so if you have an interesting topic proposal, please get in touch with the program director.


Who should attend this event?

The Preclinical Development Operations Summit is the only strategically focused preclinical development conference in the US.Primary delegates for this event are VP/ Directors/ Heads of:Preclinical ResearchPreclinical DevelopmentIn-vivo PharmacologyProcurementR&DPreclinical SafetyToxicology


  • Szczepan Baran

    Global Head of Animal Welfare and Compliance Training, Novartis

  • Harry Barnett

    Executive Chairman, Lubris BioPharm

  • Theo Hatzipetros

    Senior Scientist, ALS Therapy Development Institute

  • Barbara Hibner

    President and CSO, PercepTx

  • Diane Joseph-Mc Carthy

    Vice President, Translational Science, Enbiotix

  • Sachindra R. Joshi

    Scientist, Preclinical Pharmacology, Acceleron Pharma, Inc.

  • Shiva Kazerounian

    Principal Scientist, BERG Healthcare

  • Christopher Kruczynski

    Preclinical Safety Assessment, Vertex Pharmaceuticals

  • Alexandros Makriyannis

    Founder and Director, Center for Drug Discovery

  • Michael G. Palfreyman

    Chief Scientific Officer, Amorsa Therapeutics


Event Categories
Keywords: assessment , business , Clinical , conference , development , Health , HealthCare , industry , Innovation , Management


Events Calendar

31 1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30 1 2 3 4


VIP Life Time Subscription to our Newsletters!